Despite more cash than debt, the company's lackluster revenue growth and pre-interest, pre-tax loss suggest a need for positive EBIT before enthusiasm for this business can be justified.
Despite poor growth, the company's P/S exceeds industry peers, indicating investor hope for a business turnaround. However, without significant improvement, the share price may be seen as overvalued, risking a potential decline.
Hongmian Zhihui Science And Technology Innovationに関するコメント
まだコメントはありません